Abstract

Corticotropin-releasing factor (CRF), a neuropeptide released during stress, has been reported to modulate startle behavior, including reducing the threshold for acoustic startle responding and reducing prepulse inhibition (PPI). The central mechanisms mediating CRF system regulation of startle and PPI are still unclear. Some antipsychotic drugs attenuate CRF-induced deficits in PPI in rats and mice. Here we tested the hypothesis that indirect activation of DA 1-receptors (D 1) and DA 2-receptors (D 2) contributes to the effects of CRF on PPI. We compared the effect of central administration of h/r-CRF (0.2–0.6 nmol) on PPI in mice with either a D 1 or D 2 receptor null mutation (knockout, KO) or in mice pretreated with D 1 or D 2 receptor antagonists SCH23390 (1 mg/kg) or haloperidol (1 mg/kg). D 1 and D 2 KO mice exhibited no significant differences in their sensitivity to CRF-induced disruptions of PPI. Similarly, neither SCH23390 nor haloperidol pretreatment altered the CRF-induced disruption in PPI, although both increased PPI at baseline. CRF-induced increases in startle also remained unchanged by any of the DA receptor manipulations. These results indicate that neither D 1- nor D 2-receptor activation is necessary for CRF to exert its effects on acoustic startle and PPI in mice.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.